251 related articles for article (PubMed ID: 31192780)
21. Bioactivity of new mu and delta opioid peptides.
Capasso A
Med Chem; 2007 Sep; 3(5):480-7. PubMed ID: 17897075
[TBL] [Abstract][Full Text] [Related]
22. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
[TBL] [Abstract][Full Text] [Related]
23. Evidence for the involvement of μ-opioid and δ-opioid receptors in the antinociceptive effect caused by oral administration of m-trifluoromethyl-diphenyl diselenide in mice.
Brüning CA; Prigol M; Roehrs JA; Zeni G; Nogueira CW
Behav Pharmacol; 2010 Oct; 21(7):621-6. PubMed ID: 20729717
[TBL] [Abstract][Full Text] [Related]
24. Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents.
Kivell BM; Paton KF; Kumar N; Morani AS; Culverhouse A; Shepherd A; Welsh SA; Biggerstaff A; Crowley RS; Prisinzano TE
Molecules; 2018 Oct; 23(10):. PubMed ID: 30314288
[TBL] [Abstract][Full Text] [Related]
25. BU08073 a buprenorphine analogue with partial agonist activity at μ-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice.
Khroyan TV; Wu J; Polgar WE; Cami-Kobeci G; Fotaki N; Husbands SM; Toll L
Br J Pharmacol; 2015 Jan; 172(2):668-80. PubMed ID: 24903063
[TBL] [Abstract][Full Text] [Related]
26. Antinociceptive effects of herkinorin, a MOP receptor agonist derived from salvinorin A in the formalin test in rats: new concepts in mu opioid receptor pharmacology: from a symposium on new concepts in mu-opioid pharmacology.
Lamb K; Tidgewell K; Simpson DS; Bohn LM; Prisinzano TE
Drug Alcohol Depend; 2012 Mar; 121(3):181-8. PubMed ID: 22119134
[TBL] [Abstract][Full Text] [Related]
27. Opioid system mediated anti-nociceptive effect of agomelatine in mice.
Kasap M; Can ÖD
Life Sci; 2016 Oct; 163():55-63. PubMed ID: 27590609
[TBL] [Abstract][Full Text] [Related]
28. Kappa-opioid receptors mediate the antidepressant-like activity of hesperidin in the mouse forced swimming test.
Filho CB; Del Fabbro L; de Gomes MG; Goes AT; Souza LC; Boeira SP; Jesse CR
Eur J Pharmacol; 2013 Jan; 698(1-3):286-91. PubMed ID: 23178563
[TBL] [Abstract][Full Text] [Related]
29. Antinociceptive effect of dihydroetorphine in diabetic mice.
Kamei J; Suzuki T; Misawa M; Nagase H; Kasuya Y
Eur J Pharmacol; 1995 Feb; 275(1):109-13. PubMed ID: 7774657
[TBL] [Abstract][Full Text] [Related]
30. Pentazocine-induced antinociception is mediated mainly by μ-opioid receptors and compromised by κ-opioid receptors in mice.
Shu H; Hayashida M; Arita H; Huang W; Zhang H; An K; Wu G; Hanaoka K
J Pharmacol Exp Ther; 2011 Aug; 338(2):579-87. PubMed ID: 21543510
[TBL] [Abstract][Full Text] [Related]
31. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T
Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815
[TBL] [Abstract][Full Text] [Related]
32. Delta Opioid Receptor-Mediated Antidepressant-Like Effects of Diprenorphine in Mice.
Olson KM; Hillhouse TM; Burgess GE; West JL; Hallahan JE; Dripps IJ; Ladetto AG; Rice KC; Jutkiewicz EM; Traynor JR
J Pharmacol Exp Ther; 2023 Mar; 384(3):343-352. PubMed ID: 36456196
[TBL] [Abstract][Full Text] [Related]
33. Antidepressant-like effects of dezocine in mice: involvement of 5-HT1A and κ opioid receptors.
Shang L; Duan C; Chang S; Chang N; Jia S
Behav Pharmacol; 2021 Sep; 32(6):472-478. PubMed ID: 34101632
[TBL] [Abstract][Full Text] [Related]
34. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice.
Kamei J; Zushida K; Ohsawa M; Nagase H
Eur J Pharmacol; 2000 Mar; 391(1-2):91-6. PubMed ID: 10720639
[TBL] [Abstract][Full Text] [Related]
35. Synergistic antidepressant-like effects between a kappa opioid antagonist (LY2444296) and a delta opioid agonist (ADL5859) in the mouse forced swim test.
Huang P; Tunis J; Parry C; Tallarida R; Liu-Chen LY
Eur J Pharmacol; 2016 Jun; 781():53-9. PubMed ID: 27044434
[TBL] [Abstract][Full Text] [Related]
36. Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model.
Bedini A; Baiula M; Gentilucci L; Tolomelli A; De Marco R; Spampinato S
Peptides; 2010 Nov; 31(11):2135-40. PubMed ID: 20713109
[TBL] [Abstract][Full Text] [Related]
37. The antinociceptive effect of salvinorin A in mice.
John TF; French LG; Erlichman JS
Eur J Pharmacol; 2006 Sep; 545(2-3):129-33. PubMed ID: 16905132
[TBL] [Abstract][Full Text] [Related]
38. Redoubling the ring size of an endomorphin-2 analog transforms a centrally acting mu-opioid receptor agonist into a pure peripheral analgesic.
Piekielna J; De Marco R; Gentilucci L; Cerlesi MC; Calo' G; Tömböly C; Artali R; Janecka A
Biopolymers; 2016 May; 106(3):309-17. PubMed ID: 27038094
[TBL] [Abstract][Full Text] [Related]
39. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
[TBL] [Abstract][Full Text] [Related]
40. A role for the mu opioid receptor in the antidepressant effects of buprenorphine.
Robinson SA; Erickson RL; Browne CA; Lucki I
Behav Brain Res; 2017 Feb; 319():96-103. PubMed ID: 27818236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
